162 related articles for article (PubMed ID: 30681397)
21. Childhood vaccination against chickenpox: an analysis of benefits and costs.
Huse DM; Meissner HC; Lacey MJ; Oster G
J Pediatr; 1994 Jun; 124(6):869-74. PubMed ID: 8201469
[TBL] [Abstract][Full Text] [Related]
22. Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy.
Holl K; Sauboin C; Amodio E; Bonanni P; Gabutti G
BMC Public Health; 2016 Oct; 16(1):1103. PubMed ID: 27769206
[TBL] [Abstract][Full Text] [Related]
23. The economic value of childhood varicella vaccination in France and Germany.
Coudeville L; Brunot A; Szucs TD; Dervaux B
Value Health; 2005; 8(3):209-22. PubMed ID: 15877593
[TBL] [Abstract][Full Text] [Related]
24. Controlling varicella in the healthcare setting: the cost effectiveness of using varicella vaccine in healthcare workers.
Nettleman MD; Schmid M
Infect Control Hosp Epidemiol; 1997 Jul; 18(7):504-8. PubMed ID: 9247834
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian Sentinel Group on Pediatric Infectious Diseases.
Fornaro P; Gandini F; Marin M; Pedrazzi C; Piccoli P; Tognetti D; Assael BM; Lucioni C; Mazzi S
Pediatr Infect Dis J; 1999 May; 18(5):414-9. PubMed ID: 10353513
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial use for the management of varicella in Thailand: a retrospective observational study.
Chokephaibulkit K; Samant S; Chaisavaneeyakorn S; Kamolratanakul S; Limpadanai S; Kebede N; Stephens J; Sukarom I; Pawaskar M
Curr Med Res Opin; 2023 Jun; 39(6):873-880. PubMed ID: 37057414
[TBL] [Abstract][Full Text] [Related]
27. Varicella paediatric hospitalisations in Belgium: a 1-year national survey.
Blumental S; Sabbe M; Lepage P;
Arch Dis Child; 2016 Jan; 101(1):16-22. PubMed ID: 26130380
[TBL] [Abstract][Full Text] [Related]
28. The cost-effectiveness of varicella vaccination in Canada.
Brisson M; Edmunds WJ
Vaccine; 2002 Jan; 20(7-8):1113-25. PubMed ID: 11803072
[TBL] [Abstract][Full Text] [Related]
29. Is Europe ready to embrace a policy of universal varicella vaccination?
Ramet J; Weil-Olivier C; Sedlak W;
Int J Clin Pract; 2005 Nov; 59(11):1326-33. PubMed ID: 16236088
[TBL] [Abstract][Full Text] [Related]
30. Economic evaluation of varicella vaccination in Spain: results from a dynamic model.
Lenne X; Diez Domingo J; Gil A; Ridao M; Lluch JA; Dervaux B
Vaccine; 2006 Nov; 24(47-48):6980-9. PubMed ID: 16860909
[TBL] [Abstract][Full Text] [Related]
31. [Hospitalizations for varicella in the Hospital Infantil La Fe, Valencia,Spain, 2001-2004].
Piqueras Arenas AI; Otero Reigada MC; Pérez-Tamarit D; Asensi Botet F; Diosdado Ortín N; Santos Durantez M
An Pediatr (Barc); 2005 Aug; 63(2):120-4. PubMed ID: 16045870
[TBL] [Abstract][Full Text] [Related]
32. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
[TBL] [Abstract][Full Text] [Related]
33. Varicella epidemiology in Latin America and the Caribbean.
Ávila-Agüero ML; Beltrán S; Castillo JBD; Castillo Díaz ME; Chaparro LE; Deseda C; Debbag R; Espinal C; Falleiros-Arlant LH; González Mata AJ; Macías Parra M; Marques-Rosa F; Catalina Pírez M; Vázquez-Rivera M
Expert Rev Vaccines; 2018 Feb; 17(2):175-183. PubMed ID: 29254392
[TBL] [Abstract][Full Text] [Related]
34. Incidence and consequences of varicella in children treated for cancer in Guatemala.
Brown AEC; Asturias EJ; Melgar M; Antillon-Klussmann FA; Mettler P; Levin MJ
World J Pediatr; 2016 Aug; 12(3):320-326. PubMed ID: 27351567
[TBL] [Abstract][Full Text] [Related]
35. Does unwanted pregnancy lead to adverse health and healthcare utilization for mother and child? Evidence from low- and middle-income countries.
Hajizadeh M; Nghiem S
Int J Public Health; 2020 May; 65(4):457-468. PubMed ID: 32270238
[TBL] [Abstract][Full Text] [Related]
36. Economic evaluation of varicella vaccination in Swiss children and adolescents.
Banz K; Iseli A; Aebi C; Brunner M; Schmutz AM; Heininger U
Hum Vaccin; 2009 Dec; 5(12):847-57. PubMed ID: 19829048
[TBL] [Abstract][Full Text] [Related]
37. The burden and cost of hospitalised varicella and zoster in Australian children.
Carapetis JR; Russell DM; Curtis N
Vaccine; 2004 Dec; 23(6):755-61. PubMed ID: 15542199
[TBL] [Abstract][Full Text] [Related]
38. The cost-effectiveness of routine childhood varicella vaccination in Germany.
Banz K; Wagenpfeil S; Neiss A; Goertz A; Staginnus U; Vollmar J; Wutzler P
Vaccine; 2003 Mar; 21(11-12):1256-67. PubMed ID: 12559807
[TBL] [Abstract][Full Text] [Related]
39. Use of National Health Insurance database to evaluate the impact of public varicella vaccination program on burden of varicella in Taiwan.
Tseng HF; Tan HF; Chang CK
Vaccine; 2006 Jun; 24(25):5341-8. PubMed ID: 16713038
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of a routine varicella vaccination program for US children.
Lieu TA; Cochi SL; Black SB; Halloran ME; Shinefield HR; Holmes SJ; Wharton M; Washington AE
JAMA; 1994 Feb; 271(5):375-81. PubMed ID: 8283587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
